LIDDS.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 06:38):

LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies...

Stats
Today's Volume	49 506.00
Average Volume	135 070
Market Cap	9.93M
EPS	SEK0 ( 2024-02-21 )
Next earnings date	( SEK0 ) 2024-05-27
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.250
ATR14	SEK0.00200 (1.37%)

LIDDS AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LIDDS AB (publ) Financials

Annual	2023
Revenue:	SEK0
Gross Profit:	SEK-15.69M (0.00 %)
EPS:	SEK-0.630

FY	2023
Revenue:	SEK0
Gross Profit:	SEK-15.69M (0.00 %)
EPS:	SEK-0.630

FY	2023
Revenue:	SEK0
Gross Profit:	SEK0 (0.00 %)
EPS:	SEK0

FY	2022
Revenue:	SEK1.89M
Gross Profit:	SEK-36.62M (-1 939.62 %)
EPS:	SEK-1.000

Financial Reports:

No articles found.

LIDDS AB (publ)